Stocksigma LogoStocksigma Logo

Sun Pharma Joins White House Initiative on U.S. Medicine Pricing

On 01 Sep'26, Sun Pharma entered an agreement with the U.S. government to improve medicine affordability

Sun Pharma Joins White House Initiative on U.S. Medicine Pricing

Sun Pharmaceutical Industries Ltd 路 Press Release 路 01 Sept 2026, 7:19 am

Sun Pharma Joins White House Initiative on U.S. Medicine Pricing On 01 Sep'26, Sun Pharma entered an agreement with the U.S. government to improve medicine affordability. The company will extend Most Favored Nation (MFN) pricing to state Medicaid programs and apply it to future innovative drug launches. In return, the U.S. will delay Section 232 tariffs on Sun Pharma's innovative products for over two years. The U.S. is the company's largest market, contributing approximately 27% to global revenue. This follows the firm's agreement to acquire Organon & Co. for $11.75 billion.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements